Melanie Royce, MD, PhD, on Breast Cancer: Results From the BOLERO-4 Trial

2016 ESMO Congress
Tweet this page

Melanie Royce, MD, PhD, of the University of New Mexico, discusses phase II study findings on first-line everolimus plus letrozole in patients with ER+, HER2− advanced breast cancer. (Abstract 222O)

Advertisement

Advertisement



Advertisement

click me